Citation: Chuyu Huang, Zhishan Liu, Linping Zhao, Zuxiao Chen, Rongrong Zheng, Xiaona Rao, Yuxuan Wei, Xin Chen, Shiying Li. Metal-coordinated oxidative stress amplifier to suppress tumor growth combined with M2 macrophage elimination[J]. Chinese Chemical Letters, ;2024, 35(12): 109696. doi: 10.1016/j.cclet.2024.109696 shu

Metal-coordinated oxidative stress amplifier to suppress tumor growth combined with M2 macrophage elimination

Chuyu Huang ^{a, 1} ,
Zhishan Liu ^{a, 1} ,
Linping Zhao ^a ,
Zuxiao Chen ^a ,
Rongrong Zheng ^a ,
Xiaona Rao ^a ,
Yuxuan Wei ^a ,
Xin Chen ^{b, *,} ,
Shiying Li ^{a, b, *,}

a.
The Fifth Affiliated Hospital, Guangdong Provincial Key Laboratory of Molecular Target & Clinical Pharmacology, the NMPA and State Key Laboratory of Respiratory Disease, the School of Pharmaceutical Sciences, Guangzhou Medical University, Guangzhou 511436, China
b.
Department of Pulmonary and Critical Care Medicine, Zhujiang Hospital, Southern Medical University, Guangzhou 510280, China

chen_xin1020@163.com

lisy-sci@gzhmu.edu.cn

Received Date: 18 December 2023
Revised Date: 20 February 2024
Accepted Date: 23 February 2024
Available Online: 1 March 2024

Figures(5)

The anti-oxidative characteristic and immunosuppressive microenvironment contribute to a high resistance of tumor to many treatments. In this work, a glutathione (GSH)-responsive metal-coordinated oxidative stress amplifier (designated as CuPA) is fabricated to suppress tumor growth through elevating the cellular level of reactive oxygen species (ROS) and eliminating M2 macrophages. Among which, cooper ion (Cu²⁺) is capable of coordinating with thioredoxin (Trx) inhibitor of PX-12 and signal transducer and activator of transcription 6 (STAT6) inhibitor of AS1517499 with the assistance of distearoyl phosphoethanolamine-PEG₂₀₀₀ (DSPE-PEG₂₀₀₀), which can extensively increase the stability to enhance drug delivery in vitro and in vivo. Furthermore, CuPA can upregulate intracellular ROS to cause tumor cell death through restraining Trx and degrading GSH. Also, CuPA-mediated STAT6 inhibition results in the elimination of M2 macrophage to reverse the immunosuppressive tumor microenvironment. Finally, the elevated oxidative stress and increased immune activation amplify the synergistic antitumor effect without causing obvious side effect. This work provides a new sight for synergistic tumor suppression through chemo-immunotherapy in consideration of the complex resistant tumor microenvironment.
- Oxidative stress,
- M2 macrophage,
- Metal coordination,
- Chemotherapy,
- GSH degradation
1. [1]
  E.C. Cheung, K.H. Vousden, Nat. Rev. Cancer 22 (2022) 280–297. doi: 10.1038/s41568-021-00435-0
2. [2]
  M. Oshi, S. Gandhi, L. Yan, et al., Breast Cancer Res. Treat. 194 (2022) 231–241. doi: 10.1007/s10549-022-06633-0
3. [3]
  H. Jiang, J. Zuo, B. Li, et al., Redox Biol. 63 (2023) 102754. doi: 10.1016/j.redox.2023.102754
4. [4]
  R.G.A. Costa, S.L.R. Silva, I. Dias, et al., Redox Biol. 62 (2023) 102692. doi: 10.1016/j.redox.2023.102692
5. [5]
  C. Deng, B. Zhang, S. Zhang, et al., Cell Death Dis. 7 (2016) e2106. doi: 10.1038/cddis.2016.13
6. [6]
  Y. Tao, C. Dai, Z. Xie, et al., Chin. Chem. Lett. 35 (2024) 109170. doi: 10.1016/j.cclet.2023.109170
7. [7]
  J. Zhang, J. Yan, Y. Wang, et al., Chin. Chem. Lett. 35 (2024) 108434. doi: 10.1016/j.cclet.2023.108434
8. [8]
  H. Liu, T. Nie, X. Duan, et al., J. Control. Release 359 (2023) 132–146. doi: 10.1016/j.jconrel.2023.05.040
9. [9]
  R. Jin, Z. Liu, T. Liu, et al., Chin. Chem. Lett. 32 (2021) 3076–3082. doi: 10.1016/j.cclet.2021.03.084
10. [10]
  J. Muri, M. Kopf, Eur. J. Immunol. 53 (2023) e2249948. doi: 10.1002/eji.202249948
11. [11]
  Q. Xu, J. Zhang, Expert. Opin. Drug Discov. 17 (2022) 437–442. doi: 10.1080/17460441.2022.2045270
12. [12]
  H. Nakamura, Y. Hoshino, H. Okuyama, et al., Adv. Drug Deliv. Rev. 61 (2009) 303–309. doi: 10.1016/j.addr.2009.01.003
13. [13]
  J. Lu, A. Holmgren, Free Radic. Biol. Med. 66 (2014) 75–87.
14. [14]
  A. Jastrzab, E. Skrzydlewska, J. Enzyme Inhib. Med. Chem. 36 (2021) 362–371. doi: 10.1080/14756366.2020.1867121
15. [15]
  V. Ehrenfeld, S. Fulda, Biol. Chem. 401 (2020) 273–283. doi: 10.1515/hsz-2019-0160
16. [16]
  T. Liu, L. Sun, Y. Zhang, et al., J. Biochem. Mol. Toxicol. 36 (2022) e22942. doi: 10.1002/jbt.22942
17. [17]
  X. Yu, T. Shang, G. Zheng, et al., Chin. Chem. Lett. 33 (2022) 1895–1900. doi: 10.1016/j.cclet.2021.10.021
18. [18]
  Q. Li, F. Wang, L. Shi, et al., ACS Appl. Mater. Interfaces 14 (2022) 37280–37290. doi: 10.1021/acsami.2c05944
19. [19]
  L.C. Wang, L.C. Chang, W.Q. Chen, et al., Nat. Commun. 13 (2022) 7772. doi: 10.1038/s41467-022-35515-8
20. [20]
  I. Vitale, G. Manic, L.M. Coussens, G. Kroemer, et al., Cell Metab. 30 (2019) 36–50. doi: 10.1016/j.cmet.2019.06.001
21. [21]
  Y. Xiao, D. Yu, Pharmacol. Ther. 221 (2021) 107753. doi: 10.1016/j.pharmthera.2020.107753
22. [22]
  T.Q. Nie, H.Y. Liu, Z.W. Fang, et al., ACS Nano 17 (2023) 10925–10937. doi: 10.1021/acsnano.3c02803
23. [23]
  X. Xiang, J. Wang, D. Lu, et al., Signal Transduct. Target. Ther. 6 (2021) 75. doi: 10.1038/s41392-021-00484-9
24. [24]
  Y. Pan, Y. Yu, X. Wang, et al., Front. Immunol. 11 (2020) 583084. doi: 10.3389/fimmu.2020.583084
25. [25]
  Y.T. Wei, X.R. Wang, C. Yan, et al., Cancer Res. 82 (2022) 1991–2002. doi: 10.1158/0008-5472.can-21-4260
26. [26]
  N. Kumari, S.H. Choi, J. Exp. Clin. Cancer Res. 41 (2022) 68. doi: 10.54986/irjee/2022/oct_dec/68-72
27. [27]
  B.B. Mendes, D.P. Sousa, J. Conniot, et al., Trends. Cancer 7 (2021) 847–862. doi: 10.1016/j.trecan.2021.05.001
28. [28]
  O.M. Rahal, A.R. Wolfe, P.K. Mandal, et al., Int. J. Radiat. Oncol. Biol. Phys. 100 (2018) 1034–1043. doi: 10.1016/j.ijrobp.2017.11.043
29. [29]
  H. Xiao, Y. Guo, B. Li, et al., ACS Cent. Sci. 6 (2020) 1208–1222. doi: 10.1021/acscentsci.9b01235
30. [30]
  S. Kamerkar, C. Leng, O. Burenkova, et al., Sci. Adv. 8 (2022) eabj7002. doi: 10.1126/sciadv.abj7002
31. [31]
  S.A. Leon-Cabrera, E. Molina-Guzman, Y.G. Delgado-Ramirez, et al., Cancer Immunol. Res. 5 (2017) 385–396. doi: 10.1158/2326-6066.CIR-16-0168
32. [32]
  K. Tian, R. Feng, X. Wang, X. Wu, et al., J. Cancer Res. Ther. 18 (2022) 1409–1416. doi: 10.4103/jcrt.jcrt_3_22
33. [33]
  K. Binnemars-Postma, R. Bansal, G. Storm, et al., FASEB J. 32 (2018) 969–978. doi: 10.1096/fj.201700629r
34. [34]
  P. Gao, G. Ren, J. Liang, et al., Front. Oncol. 12 (2022) 823377. doi: 10.3389/fonc.2022.823377
35. [35]
  M.G. Mendoza-Rodriguez, C.A. Sanchez-Barrera, B.E. Callejas, et al., Int. J. Mol. Sci. 21 (2020) 2130. doi: 10.3390/ijms21062130
36. [36]
  B. Youden, R. Jiang, A.J. Carrier, et al., ACS Nano 16 (2022) 17497–17551. doi: 10.1021/acsnano.2c06337
37. [37]
  Y. Zhuang, S. Han, Y. Fang, H. Huang, et al., Coord. Chem. Rev. 455 (2022) 214360. doi: 10.1016/j.ccr.2021.214360
38. [38]
  J. Huang, R. Kong, Y. Li, et al., Chin. Chem. Lett. 35 (2024) 109254. doi: 10.1016/j.cclet.2023.109254
39. [39]
  H. Wang, Z. Xu, Q. Li, et al., Eng. Regeneration 2 (2021) 137–153. doi: 10.1504/ijvics.2021.10038095
1. [1]
  Wenbin Zhou , Yafei Gao , Xinyu Feng , Yanqing Zhang , Cong Yang , Lanxi He , Fenghe Zhang , Xiaoguang Li , Qing Li . Biomimetic nanoplatform integrates FRET-enhanced photodynamic therapy and chemotherapy for cascaded revitalization of the tumor immune microenvironment in OSCC. Chinese Chemical Letters, 2025, 36(1): 109763-. doi: 10.1016/j.cclet.2024.109763
2. [2]
  Cheng-Zhe Gao , Hao-Ran Jia , Tian-Yu Wang , Xiao-Yu Zhu , Xiaofeng Han , Fu-Gen Wu . A dual drug-loaded tumor vasculature-targeting liposome for tumor vasculature disruption and hypoxia-enhanced chemotherapy. Chinese Chemical Letters, 2025, 36(1): 109840-. doi: 10.1016/j.cclet.2024.109840
3. [3]
  Xingyu Chen , Sihui Zhuang , Weiyao Yan , Zhengli Zeng , Jianguo Feng , Hongen Cao , Lei Yu . Synthesis, antibacterial evaluation, and safety assessment of Se@PLA as a potent bactericide against Xanthomonas oryzae pv. oryzae. Chinese Chemical Letters, 2024, 35(10): 109635-. doi: 10.1016/j.cclet.2024.109635
4. [4]
  Tingting Hu , Chao Shen , Xueyan Wang , Fengbo Wu , Zhiyao He . Tumor microenvironment-sensitive polymeric nanoparticles for synergetic chemo-photo therapy. Chinese Chemical Letters, 2024, 35(11): 109562-. doi: 10.1016/j.cclet.2024.109562
5. [5]
  Zhi Li , Shuya Pan , Yuan Tian , Shaowei Liu , Weifeng Wei , Jinlin Wang , Tianfeng Chen , Ling Wang . Selenium nanoparticles enhance the chemotherapeutic efficacy of pemetrexed against non-small cell lung cancer. Chinese Chemical Letters, 2024, 35(12): 110018-. doi: 10.1016/j.cclet.2024.110018
6. [6]
  Du Liu , Yuyan Li , Hankun Zhang , Benhua Wang , Chaoyi Yao , Minhuan Lan , Zhanhong Yang , Xiangzhi Song . Three-in-one erlotinib-modified NIR photosensitizer for fluorescence imaging and synergistic chemo-photodynamic therapy. Chinese Chemical Letters, 2025, 36(2): 109910-. doi: 10.1016/j.cclet.2024.109910
7. [7]
  Xiangdong Lai , Tengfei Liu , Zengchao Guo , Yihan Wang , Jiang Xiao , Qingxiu Xia , Xiaohui Liu , Hui Jiang , Xuemei Wang . In situ formed fluorescent gold nanoclusters inhibit hair follicle regeneration in oxidative stress microenvironment via suppressing NFκB signal pathway. Chinese Chemical Letters, 2025, 36(2): 109762-. doi: 10.1016/j.cclet.2024.109762
8. [8]
  Yu-Yao Li , Xiao-Hui Li , Zhi-Xuan An , Yang Chu , Xiu-Li Wang . Room-temperature olefin epoxidation reaction by two 2D cobalt metal-organic complexes under O₂ atmosphere: Coordination and structural regulation. Chinese Chemical Letters, 2025, 36(4): 109716-. doi: 10.1016/j.cclet.2024.109716
9. [9]
  Yi Zhou , Wei Zhang , Rong Fu , Jiaxin Dong , Yuxuan Liu , Zihang Song , Han Han , Kang Cai . Self-assembly of two pairs of homochiral M₂L₄ coordination capsules with varied confined space using Tröger's base ligands. Chinese Chemical Letters, 2025, 36(2): 109865-. doi: 10.1016/j.cclet.2024.109865
10. [10]
  Haiming Wu , Gaya N. Andrew , Rajini Anumula , Zhixun Luo . Corrigendum to 'How ligand coordination and superatomic-states accommodate the structure and property of a metal cluster: Cu₄ (dppy)₄ Cl₂ vs. Cu₂₁ (dppy)₁₀ with altered photoluminescence' [Chin. Chem. Lett. 35 (2024) 108340]. Chinese Chemical Letters, 2024, 35(12): 109912-. doi: 10.1016/j.cclet.2024.109912
11. [11]
  Yunyan Li , Zimin Cai , Zhicheng Wang , Sifeng Zhu , Wendian Liu , Cheng Wang . Construction of biomimetic hybrid nanovesicles based on M1 macrophage-derived exosomes for therapy of cancer. Chinese Chemical Letters, 2025, 36(4): 109942-. doi: 10.1016/j.cclet.2024.109942
12. [12]
  Chu Chu , Yuancheng Qin , Cailing Ni , Jianping Zou . Corrigendum to "Halogenated benzothiadiazole-based conjugated polymers as efficient photocatalysts for dye degradation and oxidative coupling of benzylamines" [Chinese Chemical Letters 33 (2022) 2736–2740]. Chinese Chemical Letters, 2025, 36(2): 110616-. doi: 10.1016/j.cclet.2024.110616
13. [13]
  Xiangqian Cao , Chenkai Yang , Xiaodong Zhu , Mengxin Zhao , Yilin Yan , Zhengnan Huang , Jinming Cai , Jingming Zhuang , Shengzhou Li , Wei Li , Bing Shen . Synergistic enhancement of chemotherapy for bladder cancer by photothermal dual-sensitive nanosystem with gold nanoparticles and PNIPAM. Chinese Chemical Letters, 2024, 35(8): 109199-. doi: 10.1016/j.cclet.2023.109199
14. [14]
  Jinyu Guo , Yandai Lin , Shaohua He , Yueqing Chen , Fenglu Li , Renjie Ruan , Gaoxing Pan , Hexin Nan , Jibin Song , Jin Zhang . Utilizing dual-responsive iridium(Ⅲ) complex for hepatocellular carcinoma: Integrating photoacoustic imaging with chemotherapy and photodynamic therapy. Chinese Chemical Letters, 2024, 35(9): 109537-. doi: 10.1016/j.cclet.2024.109537
15. [15]
  Weijian Zhang , Xianyu Deng , Liying Wang , Jian Wang , Xiuting Guo , Lianggui Huang , Xinyi Wang , Jun Wu , Linjia Jiang . Poly(ferulic acid) nanocarrier enhances chemotherapy sensitivity of acute myeloid leukemia by selectively targeting inflammatory macrophages. Chinese Chemical Letters, 2024, 35(9): 109422-. doi: 10.1016/j.cclet.2023.109422
16. [16]
  Lin Li , Bingjun Sun , Jin Sun , Lin Chen , Zhonggui He . Binary prodrug nanoassemblies combining chemotherapy and ferroptosis activation for efficient triple-negative breast cancer therapy. Chinese Chemical Letters, 2024, 35(10): 109538-. doi: 10.1016/j.cclet.2024.109538
17. [17]
  Weichen Zhu , Wei Zuo , Pu Wang , Wei Zhan , Jun Zhang , Lipin Li , Yu Tian , Hong Qi , Rui Huang . Fe-N-C heterogeneous Fenton-like catalyst for the degradation of tetracycline: Fe-N coordination and mechanism studies. Chinese Chemical Letters, 2024, 35(9): 109341-. doi: 10.1016/j.cclet.2023.109341
18. [18]
  Yaping Zhang , Wei Zhou , Mingchun Gao , Tianqi Liu , Bingxin Liu , Chang-Hua Ding , Bin Xu . Oxidative cyclization of allyl compounds and isocyanide: A facile entry to polysubstituted 2-cyanopyrroles. Chinese Chemical Letters, 2024, 35(4): 108836-. doi: 10.1016/j.cclet.2023.108836
19. [19]
  Peipei CUI , Xin LI , Yilin CHEN , Zhilin CHENG , Feiyan GAO , Xu GUO , Wenning YAN , Yuchen DENG . Transition metal coordination polymers with flexible dicarboxylate ligand: Synthesis, characterization, and photoluminescence property. Chinese Journal of Inorganic Chemistry, 2024, 40(11): 2221-2231. doi: 10.11862/CJIC.20240234
20. [20]
  Feifei Wang , Hang Yao , Xinyue Wu , Yijian Tang , Yang Bai , Hui Chong , Huan Pang . Metal–organic framework and its composites modulate macrophage polarization in the treatment of inflammatory diseases. Chinese Chemical Letters, 2024, 35(5): 108821-. doi: 10.1016/j.cclet.2023.108821

Get Citation

PDF

XML

Metrics

PDF Downloads(1)
Abstract views(261)
HTML views(3)

通讯作者: 陈斌, bchen63@163.com

1.
沈阳化工大学材料科学与工程学院沈阳 110142